ID
15692
Description
Nerventra Study (Eudra CT 2007-003226-19) Study MS-LAQ-301: A multinational, multicenter, randomized, double-blind, parallel-group, placebo-controlled study, to evaluate the safety, tolerability and efficacy of daily oral administration of laquinimod 0.6 mg in subjects with relapsing remitting multiple sclerosis (RRMS)
Keywords
Versions (1)
- 6/8/16 6/8/16 -
Uploaded on
June 8, 2016
DOI
To request one please log in.
License
Creative Commons BY-NC 3.0
Model comments :
You can comment on the data model here. Via the speech bubbles at the itemgroups and items you can add comments to those specificially.
Itemgroup comments for :
Item comments for :
In order to download data models you must be logged in. Please log in or register for free.
Nerventra Study Laboratory data
Nerventra Study Laboratory data
- StudyEvent: ODM
Description
Laboratory parameter
Description
Laboratory parameter
Data type
text
Alias
- UMLS CUI [1]
- C0022885
Description
Date laboratory
Data type
date
Alias
- UMLS CUI [1,1]
- C0011008
- UMLS CUI [1,2]
- C0022885
Description
Value
Data type
float
Alias
- UMLS CUI [1]
- C0519835
Description
Unit
Data type
text
Alias
- UMLS CUI [1]
- C2348328
Description
Normal range upper limit
Data type
integer
Alias
- UMLS CUI [1,1]
- C0086715
- UMLS CUI [1,2]
- C2827740
Description
Normal range lower limit
Data type
integer
Alias
- UMLS CUI [1,1]
- C0086715
- UMLS CUI [1,2]
- C2827739
Similar models
Nerventra Study Laboratory data
- StudyEvent: ODM
C0600091 (UMLS CUI [1,2])
C0022885 (UMLS CUI [1,2])
C2827740 (UMLS CUI [1,2])
C2827739 (UMLS CUI [1,2])